Your browser doesn't support javascript.
loading
TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib.
Wang, Wen-Xian; Xu, Chun-Wei; Chen, Yan-Ping; Liu, Wei; Zhong, Li-Hua; Chen, Fang-Fang; Zhuang, Wu; Huang, Yun-Jian; Huang, Zhang-Zhou; Chen, Rong-Rong; Guan, Yan-Fang; Yi, Xin; Lv, Tang-Feng; Zhu, Wei-Feng; Lu, Jian-Ping; Wang, Xiao-Jiang; Shi, Yi; Lin, Xian-Dong; Chen, Gang; Song, Yong.
Afiliação
  • Wang WX; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou 310022, China.
  • Xu CW; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Chen YP; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Liu W; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Zhong LH; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Chen FF; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Zhuang W; Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Huang YJ; Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Huang ZZ; Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Chen RR; Geneplus-Beijing, Beijing 102200, China.
  • Guan YF; Geneplus-Beijing, Beijing 102200, China.
  • Yi X; Geneplus-Beijing, Beijing 102200, China.
  • Lv TF; Department of Respiratory Medicine, Jinling Hospital, Nanjing 210002, China.
  • Zhu WF; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Lu JP; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Wang XJ; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Shi Y; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Lin XD; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Chen G; Department of Pathology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing 210002, China.
J Thorac Dis ; 10(5): 2991-2998, 2018 May.
Article em En | MEDLINE | ID: mdl-29997966
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article